Elixinol Wellness (ELLXF) Stock Price, News & Analysis

Company Overview

Elixinol Wellness (OTCMKTS:ELLXF) is a global manufacturer and distributor of hemp-derived cannabidiol (CBD) products designed to support overall health and wellness. The company develops, sources and markets a broad range of nutraceutical and personal care offerings that leverage full-spectrum hemp oil. Its core business activities include research and development of proprietary formulations, compliance with regulatory standards, and scale manufacturing across multiple production facilities.

The company’s product portfolio encompasses dietary supplements such as tinctures, softgels and capsules, topical formulations including creams and balms, as well as functional foods and beverages infused with CBD. Elixinol Wellness has also introduced specialized pet products aimed at supporting animal well-being. Each product line is formulated to deliver consistent cannabidiol content, backed by third-party laboratory testing and quality-assurance protocols in accordance with Good Manufacturing Practices (GMP).

Elixinol Wellness serves customers through a diversified distribution network that includes e-commerce platforms, third-party retail partners, specialty health stores and branded outlets. The company has established a presence in North America, Europe, Australia and parts of Asia, adapting its offerings to meet local regulatory requirements and consumer preferences. Strategic partnerships with distribution and logistics providers underpin its ability to scale operations and enter new markets efficiently.

Founded in 1991 by hemp industry pioneer Paul Benhaim, Elixinol Wellness has built a legacy of innovation in the cannabinoid sector. The management team combines decades of experience in consumer packaged goods, natural health products and pharmaceutical manufacturing. Under this leadership, the company continues to invest in product development, scientific research and sustainable sourcing practices to reinforce its position as a trusted provider of CBD-based wellness solutions.

Key Stats

• Today's Range: $0.0088 to $0.0097
• 50-Day Range: $0.00 to $0.02
• 52-Week Range: $0.00 to $0.04
• Volume: 1,375 shs
• Average Volume: 5,398 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ELLXF Stock Analysis - Frequently Asked Questions

How have ELLXF shares performed this year?

Elixinol Wellness' stock was trading at $0.0188 on January 1st, 2025. Since then, ELLXF stock has decreased by 48.4% and is now trading at $0.0097.

How do I buy shares of Elixinol Wellness?

Shares of ELLXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:ELLXF
• CIK: N/A
• Web: www.elixinolglobal.com
• Phone: (124) 044-4585
• Fax: N/A
• Employees: 76
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A